Summit Therapeutics Inc. (SMMT)
NASDAQ · Healthcare
Summit Therapeutics Inc. Revenue 2019–2024
Summit Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Summit Therapeutics Inc. revenue for the quarter ending September 30, 2024 was 0.
- Summit Therapeutics Inc. revenue for the twelve months ending September 30, 2024 was 0, a 100.00% decrease year-over-year.
- Summit Therapeutics Inc. annual revenue for 2024 was 0.
- Summit Therapeutics Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Summit Therapeutics Inc. annual revenue for 2022 was 705000, a 61.03% decrease from 2021.
- Summit Therapeutics Inc. annual revenue for 2021 was 1.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Summit Therapeutics Inc. (SMMT) — Frequently Asked Questions
Summit Therapeutics Inc. (SMMT) is a publicly traded US company. It has a market capitalization of $9.57B. Explore SMMT's stock price, financial statements, earnings history, margins and key ratios below.
What is Summit Therapeutics Inc.'s market cap?
Summit Therapeutics Inc. (SMMT) has a market capitalization of $9.57B.
What is the SMMT stock price?
SMMT trades at $13.31 (+2.03% on the day).
Is SMMT profitable?
In fiscal 2024, Summit Therapeutics Inc. reported net income of -$221M.